ARCHIVES

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Obituary: Selma Schimmel, Founder of Vital Options, Dies of Cancer

May 23, 2014

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983